ライフサイエンスコーパス: nervous system tumor

1 Meningiomas are the most common primary nervous system tumor.

2 d to the development of benign and malignant nervous system tumors.

3 pruritus is a rare manifestation of central nervous system tumors.

4 ost common and deadly of the primary central nervous system tumors.

5 and cellular pathogenesis of NF1-associated nervous system tumors.

6 mors, representing 15% to 25% of all central nervous system tumors.

7 nting for approximately one-fifth of central nervous system tumors.

8 r benefit in patients with malignant central nervous system tumors.

9 genetic changes in the evolution of central nervous system tumors.

10 for malignant rhabdoid and childhood central nervous system tumors.

11 inked to increased aggressiveness in several nervous system tumors.

12 inhibiting prosurvival mechanisms in central nervous system tumors.

13 evaluate the incidence of MSI in 206 central nervous system tumors.

14 ma is one of the most deadly primary central nervous system tumors.

15 in human gynecological, breast, and central nervous system tumors.

16 on and acquired genetic mutations in central nervous system tumors.

17 biology and management of pediatric central nervous system tumors.

18 romes are associated with the development of nervous system tumors.

19 s represent approximately 30% of all central nervous system tumors and 80% of malignant brain tumors.

20 aracterized by multiple benign and malignant nervous system tumors and cognitive deficits.

21 oss of Merlin, patients suffer from multiple nervous system tumors and die on average around age 40.

22 uated primary human NF1-deficient peripheral nervous system tumors and found that MNKs are activated

23 vances in defining the molecular etiology of nervous system tumors and learning disabilities.

24 as constitute the second most common central nervous system tumor, and yet relatively little is known

25 aracterized by multiple benign and malignant nervous system tumors, and by learning defects in 45% of

26 re human hereditary neuropathies, peripheral nervous system tumors, and common degenerative diseases.

27 FI) is a common genetic disorder that causes nervous system tumors, and learning and memory defects i

28 Nervous system tumors are clinically challenging neoplas

29 onstrate that VHL disease-associated central nervous system tumors are composed of developmentally ar

30 Although analogous studies of rare nervous system tumors are needed, there are major barrie

31 Primary central nervous system tumors are the second most common form of

32 ghly expressed in a panel of cell lines from nervous system tumors arising from glia, although expres

33 uman neurofibromas, schwannomas, and various nervous system tumors associated with NF1 or NF2; midkin

34 ndrome in which affected individuals develop nervous system tumors at an increased frequency.

35 As treatment with chemotherapy for central nervous system tumors becomes more successful, new measu

36 e among patients without significant central nervous system tumor burden and to describe the experime

37 ly in familial schwannomas and other central nervous system tumors, but also in malignant tumors unre

38 In both breast cancers and central nervous system tumors, cancer cells differ in their abil

39 Central nervous system tumors carry grave clinical prognoses due

40 The methionine-dependent central nervous system tumor cell lines DAOY (medulloblastoma),

41 ession was low or absent in nonglial-derived nervous system tumor cell lines.

42 he TSC2 gene, seen in both renal and central nervous system tumors from TSC patients?

43 However, little is known about how central nervous system tumors guard against immune eradication.

44 as induction of humoral responses by central nervous system tumors has been reported to be minimal, w

45 tumor suppressor found to be mutated in most nervous system tumors; however, it is not mutated in gli

46 Meningiomas are common central nervous system tumors; however, the mechanisms underlyin

47 Meningiomas are common central nervous system tumors; however, the molecular mechanisms

48 une responses against peripheral and central nervous system tumors; however, variable results on the

49 cancer is medulloblastoma, a common central nervous system tumor in children.

50 (GBM), the most common and malignant central nervous system tumor in humans, is highly proliferative

51 One-third of all primary central nervous system tumors in adults are meningiomas.

52 meningiomas, one of the most common central nervous system tumors in humans.

53 port that 14% of ptc+/- mice develop central nervous system tumors in the posterior fossa by 10 month

54 ned and novel approaches to modeling central nervous system tumors, including gliomas, meningiomas, m

55 matosis 1 (NF1), are prone to development of nervous system tumors, including neurofibromas and piloc

56 ome are prone to the development of multiple nervous system tumors, including optic pathway gliomas (

57 ion syndrome are prone to the development of nervous system tumors, including schwannomas and meningi

58 vation results in the development of central nervous system tumors, including schwannomas, meningioma

59 ndrome in which affected individuals develop nervous system tumors, including schwannomas, meningioma

60 detected in normal brain, malignant central nervous system tumors, including tumors metastatic to th

61 Glioblastoma is the most common central nervous system tumor, is associated with high morbidity

62 ess the role of N-myc in neurogenesis and in nervous system tumors, it was conditionally disrupted in

63 ell growth, especially against human central nervous system tumor lines such as SF-295 cells.

64 red to astrocytomas, the most common central nervous system tumor, little is known about the molecula

65 Although meningiomas are common central nervous system tumors, little is known about the genetic

66 ns in gene expression found in human central nervous system tumors may actually contribute to the eti

67 Malignant glioma is the most common central nervous system tumor of adults and is associated with a

68 ed not only in schwannomas and other central nervous system tumors of NF2 patients but also in their

69 l age increased risk of leukemia and central nervous system tumors, older paternal age was not associ

70 (OR, 2.1; 95% CI, 1.8-2.5; P<.001), central nervous system tumors (OR, 1.7; 95% CI, 1.5-2.0; P<.001)

71 emia, neuroblastoma, retinoblastoma, central nervous system tumors, or renal or germ-cell tumors.

72 With the exception of primary central nervous system tumors, organ recovery is no longer consi

73 Childhood primary central nervous system tumors remain a therapeutic conundrum.

74 Nervous system tumors represent unique neoplasms that ar

75 t associated with the peripheral and central nervous system tumors seen in NF1.

76 nd oligodendrogliomas, as well as peripheral nervous system tumors such as neurofibromas, schwannomas

77 8), human melanoma (RPMI), and human central nervous system tumor (TE671) cells.

78 Neuroblastoma is a peripheral nervous system tumor that accounts for 8-10% of all soli

79 em gliomas (BSG) are a rare group of central nervous system tumors that arise mostly in children and

80 Meningiomas are central nervous system tumors that originate from the meningeal

81 Analysis of a central nervous system tumor tissue microarray revealed that str

82 uman Cancer Consortium convened a meeting on Nervous System Tumors to review recent advances and sugg

83 Meningiomas are common nervous system tumors, whose molecular pathogenesis is p

84 an effective antitumor agent for non-central nervous system tumor xenografts with an excellent safety